New Customs Rule Threatens Cheap Canadian Drug Imports
“There will be just a full stop of anything coming into the States,” Tim Smith, general manager of the Canadian International Pharmacy Association, told the Wall Street Journal, as millions of Americans brace for sweeping changes to cross-border medication purchases. Starting October 22, U.S. Customs and Border Protection is enforcing a new rule that requires mailed prescription drugs valued over $100 to clear formal entry through a licensed broker and a bond, effectively dismantling a decades-old exemption that allowed low-value pharmaceutical shipments to enter the country without formal commercial filing, yahoo.com reported.
While importing unapproved prescription drugs remains illegal in most cases because they lack direct Food and Drug Administration approval, enforcement had historically been inconsistent, wsbt.com reported. The shift follows an August 2025 change that required mail-order patients to pay customs fees for the first time on shipments that previously crossed duty-free. More than 2 million Americans—representing about 1.5% of U.S. adults who take prescription drugs—rely on foreign pharmacies to purchase lower-cost medications, according to a 2020 study published in JAMA Network Open cited by yahoo.com.
Tariff Enforcement and Fentanyl Inspections Drive Policy Change
Federal officials implemented the new requirement to ensure that products subject to tariffs pay appropriate duties and to help intercept the import of illegal fentanyl and counterfeit goods, according to Darren Covington, executive vice president of the Indiana Pharmacy Association, as reported by wsbt.com. Under the previous framework, shipments valued under $800 could enter the United States in standard mail boxes, subject only to random inspections by customs officers.
The revised directive ends that flexibility for any shipment regulated by other federal agencies, a category encompassing every FDA-approved drug. Shipments now face the same formal entry procedures required for large commercial cargo. Yahoo.com noted that the rule also affects smaller mail pipelines originating from India, the United Kingdom, Australia, and Turkey, though it exempts medications that travelers physically carry home across the border.
Financial Impact on Uninsured Patients and Fixed-Income Seniors
Patient advocates warn that the enforcement shift will severely harm cash-strapped, uninsured, or underinsured individuals and senior citizens on fixed incomes who depend on foreign suppliers for affordable treatments. Gabriel Levitt, founder and president of Prescription Justice, told wsbt.com that foreign pharmacies have served as a vital lifeline for patients whose prescribed medications lack adequate insurance coverage.
For blood thinners like Eliquis, which is used to prevent blood clots and lacks a generic alternative in the U.S., out-of-pocket costs can reach approximately $1,000 for a three-month supply domestically, compared to $388 in Canada, Levitt said. Patients report dramatic cost increases that force them to ration dosages. Sandra Sharp, a consumer who previously purchased medicines from Canada on a $1,000 monthly Social Security income, told wsbt.com her costs jumped from $400 for three months, leading her to take half her prescribed daily dose to afford the treatment.
Other patients face even steeper cost escalations. Diamantina Cavazos, a 38-year-old project manager in Dallas who spent two years ordering the gut-disorder drug Xifaxan from a Canadian pharmacy for about $10 a week, told yahoo.com she expects her weekly expenses to jump to $1,100 once the exemption expires and her insurer declines to cover it.
Broker Requirements and Pharmacy Responses to Border Enforcement
Licensed Canadian pharmacies and patient advocacy groups report an immediate surge in demand as consumers rush to secure medication before the deadline. Ken Hunter, executive director of the Campaign for Personal Prescription Importation, told the Wall Street Journal that organization membership grew by 20,000 people in less than two weeks, creating what he described as an avalanche of fear and concern, according to yahoo.com.
In response to the logistical hurdles of broker filings and bond requirements, British Columbia-based mail-order supplier Northwest Pharmacy notified customers that it would accept orders only on a case-by-case basis for a short period following October 9, yahoo.com reported. Meanwhile, a Department of Health and Human Services spokesperson told yahoo.com that the FDA will continue evaluating foreign drug imports on a case-by-case basis under existing guidance that permits limited supplies of unapproved foreign drugs when no domestic treatment exists and safety risks remain low.
Frequently Asked Questions About the Border Enforcement Rule
Which prescription shipments are subject to the new Customs and Border Protection rule?
The rule applies to mailed prescription drugs and other federal agency-regulated shipments valued over $100 entering the United States, requiring them to clear formal entry with a licensed broker and a bond, yahoo.com reported.
When did the enforcement shift take effect?
Shipments regulated by federal agencies had until October 22 to comply with the new formal entry requirements, following an earlier shift in August 2025 when mail-order patients began paying customs fees, according to yahoo.com.
Does the regulation apply to medications brought back by travelers?
No. The rule covers mailed shipments from countries including Canada, India, the United Kingdom, Australia, and Turkey, but it does not apply to medications that individuals physically carry home while traveling, yahoo.com reported.
Worth a look